<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02950896</url>
  </required_header>
  <id_info>
    <org_study_id>201606134</org_study_id>
    <nct_id>NCT02950896</nct_id>
  </id_info>
  <brief_title>Intraoperative Fetal Heart Rate (FHR) Monitoring: a Feasibility Study</brief_title>
  <official_title>Intraoperative Fetal Heart Rate (FHR) Monitoring: a Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fetal heart rate [FHR] monitoring is used widely to assess the well-being of the baby in the
      delivery period. If it is determined that an urgent cesarean delivery is required because of
      fetal distress, FHR is discontinued once the mother is in the operating room in order to
      allow for surgical site preparation. From this point, there is no real-time monitoring that
      permits assessment of the well-being of the infant. The investigators are evaluating the
      feasibility of intraoperative FHR monitoring using fetal ECG placed on the mother's upper
      abdominal wall and the standard acoustic device routinely used. The investigators will
      compare these to the traditional well-being tests: umbilical arterial blood gas and Apgar
      score.

      The first 15 subjects will be recruited from pregnant women who have scheduled induction of
      labor. The subsequent 40 subjects will be recruited from pregnant women who have scheduled
      cesarean sections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fetal heart rate (FHR) monitoring has become the most widely used assessment of fetal
      well-being in the peripartum period and the only routinely used method that provides
      continuous fetal monitoring. Despite a false positive rate for the detection of intrapartum
      asphyxia leading to cerebral palsy of over 99% [1-3] FHR monitoring continues to be the
      mainstay of peripartum fetal surveillance. FHR monitoring is routinely available in the
      operating room, where it is typically reassessed in cases of urgent cesarean delivery for
      fetal distress since it may direct immediate anesthetic and peripartum management. However,
      despite the ubiquitous use of FHR monitoring in labor and the typical use of FHR monitoring
      on arrival to the OR, FHR monitoring is universally stopped once anesthesia has been
      performed in order to allow abdominal skin preparation and for surgery to proceed. From the
      moment of anesthesia induction until fetal delivery, no real-time data is available that
      allows assessment of fetal well-being. A few isolated studies and case reports in the
      1970s-1980s examined intraoperative FHR monitoring using scalp-clip electrodes during
      Cesarean deliveries [4-7]. None of these studies assessed external FHR monitors or current
      anesthesia techniques. To the investigators' knowledge no studies since that time have
      examined FHR monitoring during Cesarean deliveries using external monitoring or spinal
      anesthesia
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Appropriate devices for fetal heart rate monitoring were not available.
  </why_stopped>
  <start_date>October 2016</start_date>
  <completion_date type="Actual">October 29, 2017</completion_date>
  <primary_completion_date type="Actual">October 29, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ECG of Fetal Heart Rate</measure>
    <time_frame>10 minutes of evaluable ECG reading</time_frame>
    <description>This measure will be compared to the acoustic monitoring of FHR across the same 10 minutes.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">4</enrollment>
  <condition>Fetal Monitoring</condition>
  <condition>Labor, Obstetric</condition>
  <arm_group>
    <arm_group_label>intraoperative FHR monitoring</arm_group_label>
    <description>Intraoperative fetal heart rate (FHR) monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observational fetal heart rate monitoring</intervention_name>
    <description>Patients will have fetal heart rate monitoring</description>
    <arm_group_label>intraoperative FHR monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women with scheduled induction of labor and pregnant women with schedule cesarean
        delivery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. First 15 patients only- Elective induction of labor, not yet in active labor.

          2. Subsequent 40 patients - Scheduled cesarean sections performed under spinal anesthesia

          3. Patients ages 18-45

        Exclusion Criteria:

          1. Urgent or emergent cesarean sections

          2. Cesarean sections performed under general anesthesia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather McKenzie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University St Louis School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>October 28, 2016</study_first_submitted>
  <study_first_submitted_qc>October 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2016</study_first_posted>
  <results_first_submitted>February 19, 2018</results_first_submitted>
  <results_first_submitted_qc>February 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 10, 2019</results_first_posted>
  <last_update_submitted>February 8, 2019</last_update_submitted>
  <last_update_submitted_qc>February 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 20, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/96/NCT02950896/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 15, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/96/NCT02950896/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intraoperative FHR Monitoring</title>
          <description>Intraoperative fetal heart rate (FHR) monitoring
observational fetal heart rate monitoring: Patients will have fetal heart rate monitoring</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>No results were analyzed.</population>
      <group_list>
        <group group_id="B1">
          <title>Intraoperative FHR Monitoring</title>
          <description>Intraoperative fetal heart rate (FHR) monitoring
observational fetal heart rate monitoring: Patients will have fetal heart rate monitoring</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <class_list>
            <class>
              <title>18-45 years</title>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                </category>
                <category>
                  <title>Male</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                </category>
                <category>
                  <title>Asian</title>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                </category>
                <category>
                  <title>Black or African American</title>
                </category>
                <category>
                  <title>White</title>
                </category>
                <category>
                  <title>More than one race</title>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <class_list>
            <class>
              <title>United States</title>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>external abdomianl wall fetal ECG sensors to assess FHR</title>
          <description>The primary endpoint of the feasibility study is the use of external abdominal wall fetal ECG sensors to assess FHR; its use-friendliness, the signal=noise ration and the correleation wtih acoustic data.</description>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>ECG of Fetal Heart Rate</title>
        <description>This measure will be compared to the acoustic monitoring of FHR across the same 10 minutes.</description>
        <time_frame>10 minutes of evaluable ECG reading</time_frame>
        <population>The study was terminated and no results were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Intraoperative FHR Monitoring</title>
            <description>Intraoperative fetal heart rate (FHR) monitoring
observational fetal heart rate monitoring: Patients will have fetal heart rate monitoring</description>
          </group>
        </group_list>
        <measure>
          <title>ECG of Fetal Heart Rate</title>
          <description>This measure will be compared to the acoustic monitoring of FHR across the same 10 minutes.</description>
          <population>The study was terminated and no results were analyzed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Study participation is approximately 1.5 hours.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Intraoperative FHR Monitoring</title>
          <description>Intraoperative fetal heart rate (FHR) monitoring
observational fetal heart rate monitoring: Patients will have fetal heart rate monitoring</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Heather McKenzie</name_or_title>
      <organization>Washington University School of Medicine</organization>
      <phone>3142862628</phone>
      <email>heather.mckenzie@wustl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

